Literature DB >> 15784544

Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.

Amy M Denison1, Brenda Clapper, Kevin Dybvig.   

Abstract

Phase-variable lipoproteins are commonly found in Mycoplasma species. Mycoplasma pulmonis contains a family of extensively studied phase- and size-variable lipoproteins encoded by the vsa locus. The Vsa surface proteins vary at a high frequency, the in vivo significance of which has yet to be determined. We investigated the role of Vsa phase variation in respect to tissue tropism and avoidance of the immune system in the mouse host. Mycoplasmas were cultured 3, 14, and 21 days postinoculation from the nose, lung, trachea, liver, and spleen of experimentally infected C57BL/6 (wild-type), C57BL/6-RAG-1-/- (RAG-/-), and C57BL/6-inducible nitric oxide synthase (iNOS)-/- (iNOS-/-) mice. In wild-type and iNOS-/- mice, a large number of Vsa variants were seen by 21 days postinoculation. In contrast, little Vsa variation occurred in all tissues of RAG-/- mice. Analysis of isolates from 14 days postinoculation revealed less variation of the Vsa proteins in iNOS-/- mice than in the wild type. Western blot analysis of isolates from each strain of mouse demonstrated that Vsa phase variation occurred independently of size variation, indicating no obvious selection pressure for size variants. Additionally, these experiments provided no evidence that mycoplasmas producing particular Vsa proteins adhered only to specific tissues. The data strongly indicate that Vsa phase variation is a mechanism for avoidance of the immune system with no obvious contribution to tissue tropism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784544      PMCID: PMC1087440          DOI: 10.1128/IAI.73.4.2033-2039.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Authors:  X Shen; J Gumulak; H Yu; C T French; N Zou; K Dybvig
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae.

Authors:  M D Glew; L Papazisi; F Poumarat; D Bergonier; R Rosengarten; C Citti
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Juxtaposition of an active promoter to vsp genes via site-specific DNA inversions generates antigenic variation in Mycoplasma bovis.

Authors:  I Lysnyansky; Y Ron; D Yogev
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

4.  A unique, bifunctional site-specific DNA recombinase from Mycoplasma pulmonis.

Authors:  Ramakrishnan Sitaraman; Amy M Denison; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

5.  Variable lipoprotein genes of Mycoplasma agalactiae are activated in vivo by promoter addition via site-specific DNA inversions.

Authors:  Ravenna Flitman-Tene; Sigalit Mudahi-Orenstein; Sharon Levisohn; David Yogev
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

6.  Multiple promoter inversions generate surface antigenic variation in Mycoplasma penetrans.

Authors:  Atsuko Horino; Yuko Sasaki; Tsuguo Sasaki; Tsuyoshi Kenri
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

7.  Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats.

Authors:  J Gumulak-Smith; A Teachman; A H Tu; J W Simecka; J R Lindsey; K Dybvig
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

8.  Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis.

Authors:  K Dybvig; G H Cassell
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

9.  Phase variation of the multiple banded protein in Ureaplasma urealyticum and Ureaplasma parvum.

Authors:  Stefan Monecke; Jürgen H Helbig; Enno Jacobs
Journal:  Int J Med Microbiol       Date:  2003-06       Impact factor: 3.473

10.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more
  23 in total

1.  MAP1272c encodes an NlpC/P60 protein, an antigen detected in cattle with Johne's disease.

Authors:  John P Bannantine; Cari K Lingle; Judith R Stabel; Kasra X Ramyar; Brandon L Garcia; Alex J Raeber; Pascal Schacher; Vivek Kapur; Brian V Geisbrecht
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

2.  Evidence for type III restriction and modification systems in Mycoplasma pulmonis.

Authors:  Kevin Dybvig; Z Cao; C Todd French; Huilan Yu
Journal:  J Bacteriol       Date:  2007-01-05       Impact factor: 3.490

3.  Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

4.  Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.

Authors:  Laurent-Xavier Nouvel; Marc Marenda; Pascal Sirand-Pugnet; Eveline Sagné; Michelle Glew; Sophie Mangenot; Valérie Barbe; Aurélien Barré; Stéphane Claverol; Christine Citti
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

5.  Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells.

Authors:  Jeffrey R Bolland; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2012-04-10       Impact factor: 2.742

6.  A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.

Authors:  Warren L Simmons; Jeffrey R Bolland; James M Daubenspeck; Kevin Dybvig
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

7.  Mycoplasma polysaccharide protects against complement.

Authors:  Jeffrey R Bolland; Warren L Simmons; James M Daubenspeck; Kevin Dybvig
Journal:  Microbiology       Date:  2012-04-13       Impact factor: 2.777

8.  The Vsa shield of Mycoplasma pulmonis is antiphagocytic.

Authors:  Brandon M Shaw; Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

9.  Genome of Mycoplasma arthritidis.

Authors:  Kevin Dybvig; Cao Zuhua; Ping Lao; David S Jordan; C Todd French; Anh-Hue T Tu; Ann E Loraine
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

10.  Mycoplasma biofilms ex vivo and in vivo.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2009-06       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.